INmune Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL. 

CEO
David J. Moss
CEODavid J. Moss
Employees
21
Employees21
Headquarters
Boca Raton, Florida
HeadquartersBoca Raton, Florida
Founded
2015
Founded2015
Employees
21
Employees21

INMB Key Statistics

Market cap
50.51M
Market cap50.51M
Price-Earnings ratio
-1.12
Price-Earnings ratio-1.12
Dividend yield
Dividend yield
Average volume
1.08M
Average volume1.08M
High today
$2.09
High today$2.09
Low today
$1.85
Low today$1.85
Open price
$2.04
Open price$2.04
Volume
802.85K
Volume802.85K
52 Week high
$3.24
52 Week high$3.24
52 Week low
$1.09
52 Week low$1.09

Stock Snapshot

As of today, INmune Bio(INMB) shares are valued at $1.95. The company's market cap stands at 50.51M, with a P/E ratio of -1.12.

As of 2026-07-18, INmune Bio(INMB) stock has fluctuated between $1.85 and $2.09. The current price stands at $1.95, placing the stock +5.5% above today's low and -6.7% off the high.

The INmune Bio(INMB)'s current trading volume is 802.85K, compared to an average daily volume of 1.08M.

In the last year, INmune Bio(INMB) shares hit a 52-week high of $3.24 and a 52-week low of $1.09.

In the last year, INmune Bio(INMB) shares hit a 52-week high of $3.24 and a 52-week low of $1.09.

INMB News

Investing.com 3d
INmune Bio publishes preclinical study on brain injury link to Alzheimer’s - Investing.com

...

INmune Bio publishes preclinical study on brain injury link to Alzheimer’s - Investing.com
Simply Wall St 5d
INmune Bio And 2 Other Promising Penny Stocks To Consider

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by 20%, with earnings forecast to grow annually by 18%. In light o...

INmune Bio And 2 Other Promising Penny Stocks To Consider

People also own

Based on the portfolios of people who own INMB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.